Thyroid Cancer Risk Is Not Increased in Diabetic Patients

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Tseng, Chin Hsiao ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIOGLITAZONE; ROSIGLITAZONE; SULFONYLUREA;

ARTICLE; CANCER RISK; CEREBROVASCULAR ACCIDENT; CHRONIC LUNG DISEASE; COMORBIDITY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DRUG USE; DYSLIPIDEMIA; EYE DISEASE; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RISK ASSESSMENT; SEX DIFFERENCE; THYROID CANCER; THYROID DISEASE; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; MALE; MIDDLE AGED; PHYSICAL EXAMINATION; RISK; SEX FACTORS; TAIWAN; THYROID NEOPLASMS;

EID: 84871658952     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053096     Document Type: Article

References (31)

1. Davies L, Welch HG, (2007) Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295: 2164-2167.
2. Chiang CJ, Chen YC, Chen CJ, You SL, Lai MS, et al. (2010) Cancer trends in Taiwan. Jpn J Clin Oncol 40: 897-904.
3. Roche LM, Niu X, Pawlish KS, Henry KA, (2011) Thyroid cancer incidence in New Jersey: time trend, birth cohort and socioeconomic status analysis (1979-2006). J Environ Public Health 2011: 850105.
4. McNally RJ, Blakey K, James PW, Gomez Pozo B, Basta NO, et al. (2012) Increasing incidence of thyroid cancer in Great Britain, 1976-2005: age-period-cohort analysis. Eur J Epidemiol 27: 615-622.
5. Shih SR, Chiu WY, Chang TC, Tseng CH, (2012) Diabetes and thyroid cancer risk: literature review. Exp Diabetes Res 2012: 578285.
6. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, et al. (2010) Diabetes and cancer: a consensus report. Diabetes Care 33: 1674-1685.
7. Tseng CH, (2012) Diabetes, metformin use, and colon cancer: A population-based cohort study in Taiwan. Eur J Endocrinol 167: 409-416.
8. Aschebrook-Kilfoy B, Sabra MM, Brenner A, Moore SC, Ron E, et al. (2011) Diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study. Thyroid 21: 957-963.
9. Kitahara CM, Platz EA, Beane Freeman LE, Black A, Hsing AW, et al. (2012) Physical activity, diabetes, and thyroid cancer risk: a pooled analysis of five prospective studies. Cancer Causes Control 23: 463-471.
10. Chodick G, Heymann AD, Rosenmann L, Green MS, Flash S, et al. (2010) Diabetes and risk of incident cancer: a large population-based cohort study in Israel. Cancer Causes Control 21: 879-887.
11. Almquist M, Johansen D, Björge T, Ulmer H, Lindkvist B, et al. (2011) Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes Control 22: 743-751.
12. Zhan YS, Feng L, Tang SH, Li WG, Xu M, et al. (2010) Glucose metabolism disorders in cancer patients in a Chinese population. Med Oncol 27: 177-184.
13. Chiou WK, Huang BY, Chou WY, Weng HF, Lin JD, (2011) Incidences of cancers in diabetic and non-diabetic hospitalized adult patients in Taiwan. Asian Pac J Cancer Prev 12: 1577-1581.
14. Chen GG, Vlantis AC, Zeng Q, van Hasselt CA, (2008) Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer. Curr Cancer Drug Targets 8: 367-377.
15. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, et al. (2012) Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35: 1364-1379.
16. Kim HK, Yoon JH, Kim SJ, Cho JS, Kweon SS, et al. (2012) Higher TSH level is a risk factor for differentiated thyroid cancer. Clin Endocrinol (Oxf) 2012 Aug 27. doi: 10.1111/cen.12027. [Epub ahead of print].
17. Farasat T, Cheema AM, Khan MN, (2011) Relationship of thyroid hormones with serum fasting insulin and insulin resistance in euthyroid glycemic anomalies. Pakistan J Zool 43: 379-386.
18. Kadiyala R, Peter R, Okosieme OE, (2010) Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies. Int J Clin Pract 64: 1130-1139.
19. Wang CY, Chang TC, Chen MF, (2012) Associations between subclinical thyroid disease and metabolic syndrome. Endocr J 59: 911-917.
20. Tarcin O, Abanonu GB, Yazici D, Tarcin O, (2012) Association of metabolic syndrome parameters with TT3 and FT3/FT4 ratio in obese Turkish population. Metab Syndr Relat Disord 10: 137-142.
21. Hershman JM, Konerding K, (1968) Effects of sulfonylurea drugs on the thyroid and serum protein binding of thyroxine in the rat. Endocrinology 83: 74-78.
22. Nikkila EA, Jakobson T, Jokipii SG, Karlsson K, (1960) Thyroid function in diabetic patients under long-term sulfonylurea treatment. Acta Endocrinol (Copenh) 33: 623-629.
23. Guney E, Efe B, Kebapci M, Entok E, Erenoglu E, (1999) Effects of second generation sulfonylureas on the thyroid. Turkish Journal of Endocrinology and Metabolism 4: 173-176.
24. Hu RM, Wu LM, Frank HJ, Pedram A, Levin ER, (1994) Insulin stimulates thyroid hormone receptor alpha gene expression in cultured bovine aortic endothelial cells. Mol Cell Endocrinol 103: 65-71.
25. Schultes B, Oltmanns KM, Kern W, Born J, Fehm HL, et al. (2002) Acute and prolonged effects of insulin-induced hypoglycemia on the pituitary-thyroid axis in humans. Metabolism 51: 1370-1374.
26. Hegedüs L, (2008) The potential antigoitrogenic effect of HMG-CoA reductase inhibitors (statins) in man. Clin Endocrinol (Oxf) 68: 2-3.
27. Cho NL, Lin CI, Whang EE, Carothers AM, Moore FD Jr, et al. (2010) Sulindac reverses aberrant expression and localization of beta-catenin in papillary thyroid cancer cells with the BRAFV600E mutation. Thyroid 20: 615-622.
28. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, et al. (2002) Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 87: 1941-1946.
29. Kitahara CM, Linet MS, Beane Freeman LE, Check DP, Church TR, et al. (2012) Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States. Cancer Causes Control 23: 1615-1624.
30. Cappelli C, Pirola I, Mittempergher F, De Martino E, Casella C, et al. (2012) Morbid obesity in women is associated to a lower prevalence of thyroid nodules. Obes Surg 22: 460-464.
31. Bureau of Health Promotion. Cancer Registry Annual Report 2007. Taiwan: Department of Health, Executive Yuan, 2010.